Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia.

Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia.

Item
http://www.wikidata.org/entity/Q38762256
An Allosteric Potentiator of the Dopamine D1 Receptor Increases Locomotor Activity in Human D1 Knock-In Mice without Causing Stereotypy or Tachyphylaxis.Addressing Cognitive Deficits in Schizophrenia: Toward a Neurobiologically Informed Approach.Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders.The epigenomics of schizophrenia, in the mouse.Dopaminergic mechanisms in memory consolidation and antidepressant reversal of a chronic mild stress-induced cognitive impairment`.MEF2C transcription factor is associated with the genetic and epigenetic risk architecture of schizophrenia and improves cognition in mice.The methyltransferase SETDB1 regulates a large neuron-specific topological chromatin domain.Dopamine D1 receptor subtype mediates acute stress-induced dendritic growth in excitatory neurons of the medial prefrontal cortex and contributes to suppression of stress susceptibility in mice.Gs- versus Golf-dependent functional selectivity mediated by the dopamine D1 receptor.Dopamine D4 receptor stimulation contributes to novel object recognition: Relevance to cognitive impairment in schizophrenia.Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology.Drugs for psychosis and mood: unique actions at D3, D2, and D1 dopamine receptor subtypes.Prefronto-cortical dopamine D1 receptor sensitivity can critically influence working memory maintenance during delayed response tasks.Targeting the dopamine D1 receptor or its downstream signalling by inhibiting phosphodiesterase-1 improves cognitive performance.
P2860

Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia.

Item
http://www.wikidata.org/entity/Q38762256
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia.
@en
type
label
Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia.
@en
prefLabel
Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia
@en
P2093
P2860
P304
P31
P356
10.1016/J.BIOPSYCH.2015.12.028
P407
P433
P478
P50
P577
P698
P921
P932